Retrieved Aug
This amazing substance works like magic to fix skin problems and give you that youthful glow
3 Strong Oncology & Specialty Momentum: Beyond neuroscience, BMSs growth portfolio delivered $6.9B, led by: OPDIVO (nivolumab) US HCP: $2.5B (+8%) Breyanzi (lisocabtagene maraleucel) HCP: $359M (+58%) CAMZYOS (mavacamten) US HCP: $296M (+88%) These results reinforce BMSs transformation into a data-rich, diversified biopharma, with pivotal readouts expected in 2026 across fibrosis, multiple myeloma, and autoimmune indications
Evidence-based treatments for depression, including cognitive behavioural therapy (CBT), antidepressants, and other psychological interventions, remain the first-line approaches recommended by NICE for managing depressive disorders
Glutathione IV therapy supports anti-aging by boosting collagen production, a protein essential for maintaining skin elasticity